Combined Flow‐Fluorescence in situ hybridization to HHV‐8 and EBV reveals the viral heterogeneity of primary effusion lymphoma
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29836 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Romain Stammler und 20 weiteren Autor:innen. Beteiligte Einrichtung: Inserm U976 HIPI, Institut Universitaire d'Hématologie, Université Paris Cité, Paris, France. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Herpesvirus 8, Human, In Situ Hybridization, Fluorescence, Lymphoma, Primary Effusion. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Primary effusion lymphoma (PEL) is a rare B‐cell non‐Hodgkin lymphoma associated with Kaposi Sarcoma‐associated herpesvirus (KSHV/HHV8) infection. Lymphoma cells are coinfected with Epstein‐Barr virus (EBV) in 60−80% of cases. Tools allowing a reliable PEL diagnosis are lacking. This study reports PEL diagnosis in 4 patients using a Flow‐Fluorescence in situ hybridization (FlowFISH) technique that allowed detection of differentially expressed EBV and HHV8 transcripts within the same sample, revealing viral heterogeneity of the disease. Moreover, infected cells exhibited variable expressions of CD19, CD38, CD40, and CD138. Therefore, FlowFISH is a promising tool to diagnose and characterize complex viral lymphoproliferations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inserm U976 HIPI, Institut Universitaire d'Hématologie, Université Paris Cité, Paris, France.
- Department of Clinical Immunology, Hôpital Saint Louis, AP-HP, Université Paris Cité, Paris, France.
- Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, INSERM UMR 1163, Imagine Institute, Université Paris Cité, Paris, France.
- Laboratory of Haematology, Hôpital Saint Louis, AP-HP, Université Paris Cité, Paris, France.
- National Reference Center for Castleman disease, Hôpital Saint Louis, AP-HP, Université Paris Cité, Paris, France.
- Pathology Department, Hôpital Saint Louis, AP-HP, Université Paris Cité, Paris, France.
ORCID-Profile: Maud Salmona, Jérôme Legoff, Anthony Vanjak, David Boutboul
Zitieren
APA
Stammler, R., Vacher, L., Fournier, B., Lemaire, P., Chauvel, C., Silvestrini, M. A., Knapp, S., de Frémont, G. M., Meignin, V., Salmona, M., Legoff, J., Vanjak, A., Dunogué, B., Urbain, F., Lambotte, O., Noël, N., Gérard, L., Oksenhendler, E., Galicier, L., …, & Boutboul, D. (2024). Combined Flow‐Fluorescence in situ hybridization to HHV‐8 and EBV reveals the viral heterogeneity of primary effusion lymphoma. Journal of Medical Virology. https://doi.org/10.1002/jmv.29836
Vancouver
Stammler R, Vacher L, Fournier B, Lemaire P, Chauvel C, Silvestrini MA, et al. Combined Flow‐Fluorescence in situ hybridization to HHV‐8 and EBV reveals the viral heterogeneity of primary effusion lymphoma. Journal of Medical Virology. 2024. doi:10.1002/jmv.29836
BibTeX
@article{Stammler2024,
author = {Stammler, Romain and Vacher, Lauriane and Fournier, Benjamin and Lemaire, Pierre and Chauvel, Clémentine and Silvestrini, Marc-Antoine and Knapp, Silène and de Frémont, Grégoire Martin and Meignin, Véronique and Salmona, Maud and Legoff, Jérôme and Vanjak, Anthony and Dunogué, Bertrand and Urbain, Fanny and Lambotte, Olivier and Noël, Nicolas and Gérard, Laurence and Oksenhendler, Eric and Galicier, Lionel and Latour, Sylvain and Boutboul, David},
title = {Combined Flow‐Fluorescence in situ hybridization to HHV‐8 and EBV reveals the viral heterogeneity of primary effusion lymphoma},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29836}
}
EUVIMED